Liver Injury/Regeneration News

The FDA has approved an additional indication for Evarrest, enabling the product to be used as an adjunct to hemostasis for controlling bleeding during adult liver surgery, according to a news release from the distributor.

Percutaneous hepatic perfusion increased hepatic progression free and overall survival rates in patients with liver metastases from melanoma vs. patients who underwent yttrium-90 therapy, according to data presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

Live donor liver transplantation was safe and effective for patients with acute liver failure, according to newly published data in the American Journal of Transplantation.

The FDA approved Cholbam, a cholic acid, for children and adults with bile acid synthesis disorders and peroxisomal disorders, according to a press release from the FDA.   

Acute liver failure is uncommon, according to new findings published in Gastroenterology, but over-the-counter medications and supplements were the most common causes.  

Supersonic shear imaging accurately measured various stages of liver fibrosis, but was not correlated with steatosis or any other liver disease activity, according to study data.

In a recent study, researchers in the Netherlands found that hepatic cyst infection recurrence was common and recommended oral ciprofloxacin as initial treatment for the infection.

MRI may be accurate in ruling out hepatic iron overload but not accurate enough to provide a definite diagnosis, according to recent study data.

In a cohort of patients with HIV, microRNAs, including miRNA-122, miRNA-22 and miRNA-34a, accurately predicted liver injury, according to new study data. 

People who consumed three or more cups of coffee per day lowered their chance of having high liver enzyme levels, indicating coffee could be associated with a healthy liver, according to study data.